ANVS,Annovis Bio, Inc. | Healthcare

Healthcare

ANVS

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Annovis Bio, Inc.ANVS

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration.

The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases.

It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia.

The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Latest News >

Rocket Lab Launches HASTE Suborbital Mission

Nov 18, 2025

02:56 PM EST, 11/18/2025 (MT Newswires) -- Rocket Lab ( RKLB ) said Tuesday it has successfully launched a suborbital mission using its HASTE launch vehicle for the Defense Innovation Unit and Missile Defense Agency. The mission deployed a government-provided primary payload and multiple secondary payloads by federal and industry partners, the company said. Price: 43.56, Change: +0.24, Percent Change:...

Looking At Rocket Lab's Recent Unusual Options Activity

Nov 18, 2025

Financial giants have made a conspicuous bullish move on Rocket Lab ( RKLB ). Our analysis of options history for Rocket Lab ( RKLB ) revealed 59 unusual trades. Delving into the details, we found 44% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 17 were puts, with a value of $1,496,676,...

Reply at Microsoft Ignite 2025: Showcasing AI Innovation, Copilot Experiences, and Intelligent Enterprise Solutions

Nov 18, 2025

CHICAGO--(BUSINESS WIRE)-- Reply [EXM, STAR: REY] is taking part in Microsoft Ignite 2025, a premier event for technology professionals and decision-makers hosted by Microsoft, held from November 18 to 21 in San Francisco, California. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251118836834/en/ A trusted Microsoft partner since 1996, Reply empowers organizations to innovate with Microsoft technologies, driving...

Suja Life Announces Confidential Submission of Draft Registration Statement

Nov 18, 2025

OCEANSIDE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have...